Soleil Securities
http://www.soleilgroup.com/index.shtmlSoleil Securities provides equity research for institutional investors.
Soleil Securities Reiterates a 'Buy' on Hologic (HOLX); Continued Confidence on Tomosynthesis Launch
-
Soeil Raises Price Target on Hologic (HOLX) Maintaisn Buy Rating
-
Notable Analyst Rating Changes 09/14: HOLX, MRX, TOT Upgraded; CPB, XOM, NWL, IPXL Downgraded
-
Soleil Upgrades Hologic (HOLX) to Buy, Starts Amgen (AMGN) at Buy
-
Soleil Securities Upgrades Hologic (HOLX) to Hold
-
Notable Analyst Rating Changes 9/2: TXT, CBE, SI, PAY, BBD Upgraded; ROK, GIS, HOLX, DHI, RYL, NVAX Downgraded
-
Unusual 11 Mid-Day Movers 5/5: ATRC, ALY, PEGA, ALD Higher; HLIT, PQ, HOLX, LM Lower
-
Notable Analyst Rating Changes 5/5: RIMM, MGM, LVS, MCK, TREE Upgraded; HOLX, N, APC, TASR Downgraded
-
Morning Movers 5/5: CALL, CTIC, ATRC, PEGA, ACAD Higher; HLIT, HOLX, DW, PQ, MYGN Lower
-
Soleil Securities Downgrades Hologic (HOLX) to Sell; Cites Delay in Tomosynthesis
-
Pre-Open Movers: Solars Stocks Sees Continue Momentum, Maguire Properties (MPG) Lower As CEO Ousted
-
Soleil Securities Downgrades Hologic (HOLX) to Hold
-
Hologic (HOLX) volatility Up into EPS & Outlook
